Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

199 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Strategies of therapeutic complement inhibition.
Mollnes TE, Kirschfink M. Mollnes TE, et al. Among authors: kirschfink m. Mol Immunol. 2006 Jan;43(1-2):107-21. doi: 10.1016/j.molimm.2005.06.014. Mol Immunol. 2006. PMID: 16011851 Review.
Complement analysis in the 21st century.
Mollnes TE, Jokiranta TS, Truedsson L, Nilsson B, Rodriguez de Cordoba S, Kirschfink M. Mollnes TE, et al. Among authors: kirschfink m. Mol Immunol. 2007 Sep;44(16):3838-49. doi: 10.1016/j.molimm.2007.06.150. Mol Immunol. 2007. PMID: 17768101 Review.
Increased Complement Factor B and Bb Levels Are Associated with Mortality in Patients with Severe Aortic Stenosis.
Shahini N, Ueland T, Auensen A, Michelsen AE, Ludviksen JK, Hussain AI, Pettersen KI, Aakhus S, Espeland T, Lunde IG, Kirschfink M, Nilsson PH, Mollnes TE, Gullestad L, Aukrust P, Yndestad A, Louwe MC. Shahini N, et al. Among authors: kirschfink m. J Immunol. 2019 Oct 1;203(7):1973-1980. doi: 10.4049/jimmunol.1801244. Epub 2019 Sep 6. J Immunol. 2019. PMID: 31492744 Clinical Trial.
Modern complement analysis.
Kirschfink M, Mollnes TE. Kirschfink M, et al. Clin Diagn Lab Immunol. 2003 Nov;10(6):982-9. doi: 10.1128/cdli.10.6.982-989.2003. Clin Diagn Lab Immunol. 2003. PMID: 14607856 Free PMC article. Review. No abstract available.
Complement analysis in clinic and research.
Mollnes TE, Kirschfink M. Mollnes TE, et al. Among authors: kirschfink m. Adv Exp Med Biol. 2006;586:361-80. doi: 10.1007/0-387-34134-X_24. Adv Exp Med Biol. 2006. PMID: 16893084 Review. No abstract available.
Complement resistance of tumor cells: basal and induced mechanisms.
Jurianz K, Ziegler S, Garcia-Schüler H, Kraus S, Bohana-Kashtan O, Fishelson Z, Kirschfink M. Jurianz K, et al. Among authors: kirschfink m. Mol Immunol. 1999 Sep-Oct;36(13-14):929-39. doi: 10.1016/s0161-5890(99)00115-7. Mol Immunol. 1999. PMID: 10698347 Review.
Complement in human diseases: Lessons from complement deficiencies.
Botto M, Kirschfink M, Macor P, Pickering MC, Würzner R, Tedesco F. Botto M, et al. Among authors: kirschfink m. Mol Immunol. 2009 Sep;46(14):2774-83. doi: 10.1016/j.molimm.2009.04.029. Epub 2009 May 28. Mol Immunol. 2009. PMID: 19481265 Review.
199 results